Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Office Of Drug Safety In Transition; Director Raczkowski Joins Cephalon

Oct 06 2003

• By The Pink Sheet

Related Content

Provigil Likely To Add Two New Claims; Broad Sleepiness Indication May Wait

Sep 29 2003

GSK Lotronex Plan Follows Accutane Model; Relaunch “Months” Away

Jun 10 2002

Anesta Actiq Detailing To 2,500 Specialists To Begin In March

Nov 09 1998

FDA Office Of Drug Safety Director-Designate Is ODE III Deputy Raczkowski

Aug 05 2002

Provigil Revamped Marketing Campaign To Launch After FDA Cites Promotions

Jan 21 2002

Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi

Jan 21 2002

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window